GSK3B and cancer: Aberrant activity and expression of GSK3β, as well as defects in its inhibitory regulation, contribute to the pathogenesis and progression of common diseases, including type 2 diabetes mellitus, neurodegenerative diseases (e.g., Alzheimer’s disease), inflammatory and immunological diseases, and cancer[130,131].